Sort
82,697 grants matching “vaccine development”
Epithelial innate signaling in airway inflammation and remodeling
$2,149,585Roberto P Garofalo · University Of Texas Med Br Galveston · P01 · FY2019 · AI
HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)
$2,149,542Stephen A Spector · University Of California, San Diego · UM1 · FY2023 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,149,178Stephen A Spector · University Of California, San Diego · UM1 · FY2018 · AI
Center of Biomedical Research Excellence in Pathogen Host Interactions
$2,148,925Stephen B Pruett · Mississippi State University · P20 · FY2020 · GM
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,148,642Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of Novel Immunogens for Vaccines to HIV-1
$2,148,589Robert Gerald Whalen · Maxygen, Inc. · P01 · FY2007 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum.
$2,148,172Justin D. Radolf · University Of Connecticut Sch Of Med/Dnt · U19 · FY2023 · AI
Structural Biology Of Virus Assembly
$2,147,616Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$2,147,209Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Studies of the SARS-CoV-2 Spike Protein
$2,147,209Jay A Berzofsky · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Center of Biomedical Research Excellence in Pathogen Host Interactions
$2,146,848Stephen B Pruett · Mississippi State University · P20 · FY2019 · GM
The Biology of HIV Infections
$2,146,087Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection
$2,145,755Anna Wald · University Of Washington · U19 · FY2019 · AI
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
$2,145,532David I Watkins · University Of Miami School Of Medicine · P01 · FY2013 · AI
Center of Biomedical Research Excellence in Pathogen Host Interactions
$2,144,923Stephen B Pruett · Mississippi State University · P20 · FY2021 · GM
Immunobiology and Pathogenesis of Pulmonary Tularemia (Metzger, PD)
$2,144,292Dennis W. Metzger · Albany Medical College · P01 · FY2012 · AI
Pandemic Influenza Translational Research and novel universal countermeasure development
$2,144,187Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
HIV VACCINE TRIAL CLINICAL UNIT
$2,144,184Harvard University (Medical School) · U01 · FY2004 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$2,144,081Johns Hopkins University · U01 · FY2004 · AI
Adjuvant Development Program in the context of vaccines to protect against Y. pestis and Shigella.
$2,143,971Robert Ernst · University Of Maryland Baltimore · N01 · FY2021 · AI
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$2,143,287Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Washington University SPORE in Pancreatic Cancer
$2,143,077William G Hawkins · Washington University · P50 · FY2017 · CA
Emerging and High Risk Pathogens
$2,142,856Michael R Holbrook · University Of Texas Med Br Galveston · UC7 · FY2010 · AI
Advance Veterinary Services
$2,142,856Slobodan Paessler · University Of Texas Med Br Galveston · UC7 · FY2009 · AI
Advance Veterinary Services
$2,142,856Slobodan Paessler · University Of Texas Med Br Galveston · UC7 · FY2010 · AI